R. Schoenleber

发表

Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in Vivo*

M. Gerritsen, T. Collins, J. Best, 1997, The Journal of Biological Chemistry.

Indanylacetic acids as PPAR-δ activator insulin sensitizers

David P. Dickson, J. Livingston, T. Claus, 2007 .

SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer.

L. Perkins, I. Enyedy, Antonella Bacchiocchi, 2007, Bioorganic & medicinal chemistry letters.

Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups—new classes of PPAR γ/δ and PPAR α/γ/δ agonists

Xin Ma, J. Livingston, T. Claus, 2007 .

1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors.

J. S. Johnson, T. Turner, S. Wilhelm, 2000, Bioorganic & medicinal chemistry letters.

Phycobiliprotein-bilin linkage diversity. I. Structural studies on A- and D-ring-linked phycocyanobilins.

A. Glazer, J. Nagy, A. V. Klotz, 1986, The Journal of biological chemistry.

CHROMOPEPTIDES FROM PHYCOERYTHRINS. STRUCTURE AND LINKAGE OF A PHYCOERYTHROBILIN TRYPTIC TRIPEPTIDE DERIVED FROM A B-PHYCOERYTHRIN

A. Glazer, D. Lundell, H. Rapoport, 1983 .

Bilin attachment sites in the alpha and beta subunits of B-phycoerythrin. Structural studies on the singly linked phycoerythrobilins.

A. Glazer, D. Lundell, H. Rapoport, 1984, The Journal of biological chemistry.

Bilin attachment sites in the alpha and beta subunits of B-phycoerythrin. Structural studies on a doubly peptide-linked phycoerythrobilin.

A. Glazer, D. Lundell, H. Rapoport, 1984, The Journal of biological chemistry.

Relative stereochemistry of the A ring of plant bile pigments

H. Rapoport, R. Schoenleber, Youseung. Kim, 1984 .

Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity.

Astrid A. Ortiz, Andrea Mcclure, D. Bierer, 2007, Journal of medicinal chemistry.

Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.

J. McKelvy, M. Clagett-Dame, R. Schoenleber, 1989, Biochimica et biophysica acta.

Synthesis and dopaminergic activity of 3-substituted 1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-1H-2-benzopyrans: characterization of an auxiliary binding region in the D1 receptor.

J. Kebabian, R. Mackenzie, R. Perner, 1991, Journal of medicinal chemistry.

Synthesis and dopaminergic activity of 3-substituted 1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-1H-2-benzopyrans: characterization of an auxiliary binding region in the D1 receptor.

J. Kebabian, R. Mackenzie, R. Perner, 1991, Journal of medicinal chemistry.

(1R,3S)-1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2-benzopyran: a potent and selective D1 agonist.

J. Kebabian, R. Mackenzie, R. Schoenleber, 1990, Journal of medicinal chemistry.

Synthesis and pharmacological evaluation of 1-(aminomethyl)-3,4-dihydro-5-hydroxy-1H-2-benzopyrans as dopamine D1 selective ligands.

J. Kebabian, M. Michaelides, R. Mackenzie, 1991, Journal of medicinal chemistry.

Indanylacetic Acid Derivatives Carrying 4-Thiazolyl-phenoxy Tail Groups, a New Class of Potent PPAR α/γ/δ Pan Agonists: Synthesis, Structure−Activity Relationship, and In Vivo Efficacy

Xin Ma, J. Livingston, T. Claus, 2007 .

A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets.

J. Kebabian, P. Jenner, M. Williams, 1992, European journal of pharmacology.

A68930: A potent agonist specific for the dopamine D1 receptor

J. Kebabian, R. Mackenzie, D. R. Britton, 1992, Neurochemistry International.

A68930: a potent agonist selective for the dopamine D1 receptor.

J. Kebabian, L. Bednarz, C. Briggs, 1991, European journal of pharmacology.

(1R,3S)-1-(Aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2- benzopyran: A Potent and Selective D1 Agonist.

J. Kebabian, R. Mackenzie, R. Schoenleber, 1991 .

1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors.

J. S. Johnson, T. Turner, S. Wilhelm, 2000, Bioorganic & medicinal chemistry letters.

Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo.

M. Gerritsen, T. Collins, J. Best, 1997, The Journal of biological chemistry.

Synthesis and pharmacological characterization of a potent, orally active p38 kinase inhibitor.

S. Wilhelm, W. Scott, J. Pirro, 2002, Bioorganic & medicinal chemistry letters.

Discovery of a new class of p38 kinase inhibitors.

J. S. Johnson, S. Wilhelm, W. Scott, 2000, Bioorganic & medicinal chemistry letters.

A68930: a potent and specific agonist for the D-1 dopamine receptor.

J. Kebabian, C. Briggs, J. McKelvy, 1990, American journal of hypertension.

PDE-10A inhibitors as insulin secretagogues.

Lei Zhu, J. Livingston, T. Claus, 2007, Bioorganic & medicinal chemistry letters.

A novel estrogen receptor ligand template.

J. Dumas, R. Sibley, R. Schoenleber, 2003, Bioorganic & medicinal chemistry letters.